SCHEMBL29671200

SCHEMBL29671200

CN(C)S(=O)(=O)c1c(F)c(F)c(F)c(F)c1C(=O)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ATM Q13315 1/20 0.50
▸ ALDH1A1 P00352 5/20 0.47
▸ CA1 P00915 3/20 0.46
▸ CA2 P00918 3/20 0.46
▸ CA12 O43570 2/20 0.46
▸ CA9 Q16790 2/20 0.46
▸ CA14 Q9ULX7 2/20 0.46
▸ CA3 P07451 1/20 0.46
▸ CA4 P22748 1/20 0.46
▸ CA6 P23280 1/20 0.46
▸ CA5A P35218 1/20 0.46
▸ CA7 P43166 1/20 0.46
▸ CA13 Q8N1Q1 1/20 0.46
▸ CA5B Q9Y2D0 1/20 0.46
▸ MEN1 O00255 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ RAB9A P51151 1/20 0.45
▸ SRD5A2 P31213 1/20 0.44
▸ LMNA P02545 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29671224 0.80 HSD11B1 (0.41) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL29671327 0.78 MAPT (0.43) ALDH1A1CA1CA2MEN1KMT2A
SCHEMBL29671205 0.78 TRPV4 (0.50) ALDH1A1NPC1RAB9ASRD5A2LMNA
SCHEMBL28762086 0.72 ATM (0.51) ATMALDH1A1CA1CA2CA12
SCHEMBL29671227 0.71 CYP19A1 (0.50) ALDH1A1CA1CA2CA12CA9
SCHEMBL29671286 0.70 HDAC6 (0.34) CA1CA2CA12CA7CA13
SCHEMBL1164063 0.69 CA1 (0.72) ATMALDH1A1CA1CA2CA12
SCHEMBL975118 0.69 SRD5A2 (0.83) ALDH1A1CA1CA2CA12CA9
SCHEMBL10723714 0.69 SRD5A2 (0.83) ALDH1A1CA1CA2CA12CA9
SCHEMBL29671232 0.69 HDAC6 (0.33) CA1CA2CA12CA7CA13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12559454-B2 Benzenesulfonamide derivatives and uses thereof 2692372 ONTARIO, INC. (CA) 2026-02-24 — — US disclosed
US-20220281812-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF 2692372 ONTARIO INC (CA) 2022-09-08 — — US disclosed
EP-4017843-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF 2692372 Ontario, Inc. (CA) 2022-06-29 — — EP disclosed
CN-114502533-A Benzenesulfonamide derivatives and use thereof 2692372安大略公司 2022-05-13 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559454-B2 Benzenesulfonamide derivatives and uses thereof NR2E1, NR2C2, NR3C1 ATM 4189/4885ALDH1A1 4335/4885CA1 2665/4885
US-20220281812-A1 BENZENESULFONAMIDE DERIVATIVES AND USES THEREOF BCR, ARSA, VHL ATM 1697/4885ALDH1A1 2734/4885CA1 4526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback